Sulfasalazine in rheumatoid arthritis. A double-blind, placebo-controlled trial.

No abstract is available for this paper.

• Publication year

  1986

• Venue

  Arthritis & Rheumatism

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 2879544
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Intestinal Clostridium perfringens in rheumatoid arthritis and other collagen diseases.

  2009cited by this paper
• Does sulphasalazine cause folate deficiency in rheumatoid arthritis?

  1985cited by this paper
• Sulfasalazine in severe rheumatoid arthritis: a study to assess potential correlates of efficacy and toxicity.

  1985cited by this paper
• Effect of acetylator phenotype on efficacy and toxicity of sulphasalazine in rheumatoid arthritis.

  1985cited by this paper
• Pulmonary infiltrates and eosinophilia associated with sulfasalazine.

  1984cited by this paper
• Outcome of attempts to treat rheumatoid arthritis with gold, penicillamine, sulphasalazine, or dapsone.

  1984cited by this paper
• Folate status in patients receiving maintenance doses of sulfasalazine.

  1983cited by this paper
• Inhibition of platelet thromboxane synthetase by sulfasalazine.

  1983cited by this paper
• Sulfasalazine. Adverse effects and desensitization.

  1983cited by this paper
• A biochemical assessment of sulphasalazine in rheumatoid arthritis.

  1982cited by this paper
• Sulfasalazine intolerance. A retrospective survey of the reasons for discontinuing treatment with sulfasalazine in patients with chronic inflammatory bowel disease.

  1982cited by this paper
• Sulfasalazine inhibits the synthesis of chemotactic lipids by neutrophils.

  1982cited by this paper
• Multiple haematologic abnormalities associated with sulfasalazine.

  1982cited by this paper
• Effect of metronidazole and sulfasalazine on the normal human faecal flora.

  1981cited by this paper
• Preliminary criteria for clinical remission in rheumatoid arthritis.

  1981cited by this paper
• Effects of sulfasalazine on selected lymphocyte subpopulationsin vivo andin vitro

  1979cited by this paper
• Comparative analysis of systemic immunological parameters in ulcerative colitis and idiopathic proctitis: effects of sulfasalazine in vivo and in vitro.

  1978cited by this paper
• Clinical Pharmacokinetics of Sulphasalazine

  1976cited by this paper
• Effects of sulphasalazine (Salazopyrin) on faecal flora in patients with inflammatory bowel disease

  1974cited by this paper
• 1958 Revision of diagnostic criteria for rheumatoid arthritis.

  1959cited by this paper
• Salicylazosulfapyridine (salazopyrin or azopyrin) in rheumatoid arthritis and experimental polyarthritis.

  1950cited by this paper
• Salazopyrin in the Treatment of Rheumatoid Arthritis

  1949cited by this paper
• The treatment of rheumatic polyarthritis with acid azo compounds.

  1948cited by this paper

• Monotreatment With Conventional Antirheumatic Drugs or Glucocorticoids in Rheumatoid Arthritis

  2023cites this paper
• Mesalazine Suppresses Proinflammatory Cytokines in Patients with Acute Anterior Uveitis Independently of HLA-B27

  2021cites this paper
• The Microbiome in Rheumatic Diseases and Infection

  2018cites this paper
• Mechanisms, impact and management of pain in rheumatoid arthritis

  2014cites this paper
• Is There a Role for Antibiotics in the Treatment of Patients with Rheumatoid Arthritis?

  2012cites this paper
• Rational Use of Disease-Modifying Antirheumatic Drugs

  2012cites this paper
• Elderly Onset Rheumatoid Arthritis

  2009cites this paper
• Effects of Sulfasalazine Treatment in Juvenile Idiopathic Arthritis: Clinical and Radiological Observations

  2007cites this paper
• Disease-modifying antirheumatic drug use in the elderly rheumatoid arthritis patient.

  2007cites this paper
• Successful treatment of recalcitrant chronic idiopathic urticaria with sulfasalazine.

  2006cites this paper
• Treatment of rheumatoid arthritis with ornidazole: a randomized, double-blind, placebo-controlled study

  2006cites this paper
• Successfully treated sulphasalazine-Induced fulminant hepatic failure, Thrombocytopenia and Erythroid Hypoplasia with intravenous immunoglobulin

  2005cites this paper
• Disease-modifying antirheumatic drug use in the elderly rheumatoid arthritis patient.

  2005cites this paper
• Sulphasalazine in the treatment of children with chronic arthritis

  2005cites this paper
• Sulphasalazine versus penicillamine in the treatment of rheumatoid arthritis

  2004cites this paper
• The treatment of rheumatoid arthritis.

  2004cites this paper
• Pharmacological treatment of established rheumatoid arthritis.

  2003cites this paper
• Practical Prescribing Guidelines for Rheumatoid Arthritis

  2003cites this paper
• Safety and efficacy of disease-modifying antirheumatic agents in rheumatoid arthritis and juvenile rheumatoid arthritis

  2003cites this paper
• Leflunomide, a new disease-modifying drug for treating active rheumatoid arthritis in methotrexate-controlled phase II clinical trial.

  2003cites this paper
• The effect of sulfasalazine on rheumatoid arthritic synovial tissue chemokine production.

  2002cites this paper
• Sulphasalazine and lung toxicity

  2002cites this paper
• Methotrexate, hydroxychloroquine, and intramuscular gold in rheumatoid arthritis: relative area under the curve effectiveness and sequence effects.

  2002cites this paper
• Adverse effects of sulfasalazine in patients with rheumatoid arthritis are associated with diplotype configuration at the N-acetyltransferase 2 gene.

  2002cites this paper
• Sulfasalazine therapy for juvenile rheumatoid arthritis.

  2002cites this paper
• Treating rheumatoid arthritis early with disease modifying drugs reduces joint damage: a randomised double blind trial of sulphasalazine vs diclofenac sodium.

  2002cites this paper
• Safety and Efficacy of Disease-Modifying Anti-Rheumatic Agents

  2002cites this paper
• Effects of sulfasalazine treatment on serum immunoglobulin levels in children with juvenile chronic arthritis.

  2001cites this paper
• Effects of sulfasalazine treatment on serum immunoglobulin levels in children with juvenile chronic arthritis

  2001cites this paper
• Old and new drugs used in rheumatoid arthritis: a historical perspective. Part 1: the older drugs.

  2001cites this paper
• Is it Crohn's disease? A severe systemic granulomatous reaction to sulfasalazine in patient with rheumatoid arthritis

  2001cites this paper
• Sulfasalazine for rheumatoid arthritis.

  2000cites this paper
• Old and New Drugs Used in Rheumatoid Arthritis: A Historical Perspective

  2000cites this paper
• Efficacy and safety of leflunomide compared with placebo and sulphasalazine in active rheumatoid arthritis: a double-blind, randomised, multicentre trial. European Leflunomide Study Group.

  1999cites this paper
• Sulfasalazine treatment for rheumatoid arthritis: a metaanalysis of 15 randomized trials.

  1999cites this paper
• Multiple Sclerosis Clinical Trials: Old and New Challenges

  1998cites this paper
• Sulfasalazine for treating rheumatoid arthritis

  1998cites this paper
• Sulfasalazine in the treatment of juvenile chronic arthritis: a randomized, double-blind, placebo-controlled, multicenter study. Dutch Juvenile Chronic Arthritis Study Group.

  1998cites this paper
• The Mayo Clinic-Canadian cooperative trial of sulfasalazine in active multiple sclerosis

  1998cites this paper
• Treatment of rheumatoid arthritis.

  1997cites this paper
• Treatment of early rheumatoid arthritis with minocycline or placebo: results of a randomized, double-blind, placebo-controlled trial.

  1997cites this paper
• Sulphasalazine in the treatment of rheumatoid arthritis.

  1997cites this paper
• Therapie der juvenilen chronischen Oligoarthritis mit Sulfasalazin

  1997cites this paper
• Pneumonitis induced by sulphasalazine.

  1997cites this paper
• Folate and homocysteine status and haemolysis in patients treated with sulphasalazine for arthritis.

  1996cites this paper
• Assessing the relative sensitivity to change of rheumatoid arthritis activity measures: is the type of treatment an important third variable?

  1996cites this paper
• Sulfasalazine therapy for juvenile rheumatoid arthritis.

  1996cites this paper
• Treatment of rheumatoid arthritis with methotrexate alone, sulfasalazine and hydroxychloroquine, or a combination of all three medications.

  1996cites this paper
• Combination sulfasalazine and methotrexate in the management of rheumatoid arthritis.

  1996cites this paper
• The history of the use of sulphasalazine in rheumatology.

  1995cites this paper
• Sulfasalazine. A review of its pharmacological properties and therapeutic efficacy in the treatment of rheumatoid arthritis.

  1995cites this paper
• Safety and effectiveness of leflunomide in the treatment of patients with active rheumatoid arthritis. Results of a randomized, placebo-controlled, phase II study.

  1995cites this paper
• 5-Aminosalicylic acid abrogates T-cell proliferation by blocking interleukin-2 production in peripheral blood mononuclear cells.

  1995cites this paper
• Sulfasalazine therapy for psoriatic arthritis: a double blind, placebo controlled trial.

  1995cites this paper
• A double-blind controlled study comparing sulphasalazine with placebo in rheumatoid factor (RF)-negative rheumatoid arthritis

  1995cites this paper
• Lichen planus in patients with rheumatoid arthritis treated with sulfasalazine.

  1995cites this paper
• Clinical efficacy of sulphasalazine--a review.

  1995cites this paper
• Approach to the patient with rheumatoid arthritis.

  1994cites this paper
• METABOLISM OF DRUGS BY LEUKOCYTES

  1994cites this paper
• Sulphasalazine desensitisation in patients with arthritis

  1994cites this paper
• Rheumatoid Arthritis in the Aged

  1993cites this paper
• The 'natural' history of active rheumatoid arthritis over 3-6 months--an analysis of patients enrolled into trials of potential disease-modifying anti-rheumatic drugs, and treated with placebo.

  1993cites this paper
• Rheumatoid arthritis: a risk factor for sulphasalazine toxicity? A meta-analysis.

  1993cites this paper
• Toxicity of sulphasalazine in rheumatoid arthritis. Possible protective effect of rheumatoid factors and corticosteroids.

  1993cites this paper
• Unsubstantiated "risk" of antifolate toxicity with combination methotrexate and sulfasalazine therapy.

  1993cites this paper
• Non‐steroidal anti‐inflammatory drugs and slow‐acting anti‐rheumatic drugs in juvenile rheumatoid arthritis

  1993cites this paper
• Actions of sulphasalazine and its metabolites on polymorphonuclear leucocyte superoxide

  1993cites this paper
• Sulphasalazine and aminosalicylates in rheumatoid and related arthropathies

  1993cites this paper
• Sulfasalazine in early rheumatoid arthritis. A 48-week double-blind, prospective, placebo-controlled study.

  1993cites this paper
• Sulfasalazine neurotoxicity: a report of aseptic meningitis and a review of the literature.

  1993cites this paper
• Desensitization to sulphasalazine in patients with arthritis.

  1993cites this paper
• Management of early inflammatory arthritis. The long-term outcome and justification for early treatment.

  1992cites this paper
• Changes in normal glycosylation mechanisms in autoimmune rheumatic disease.

  1992cites this paper
• Sulfasalazine in early rheumatoid arthritis. The Australian Multicentre Clinical Trial Group.

  1992cites this paper
• Adverse effects of sulphasalazine

  1992cites this paper
• Sulphasalazine-induced eosinophilic pneumonia.

  1992cites this paper
• Recombinant human interferon gamma in the treatment of rheumatoid arthritis: double blind placebo controlled study.

  1992cites this paper
• Meta-analysis of second-line antirheumatic drugs: sample size bias and uncertain benefit.

  1992cites this paper
• [Therapeutic maintenance and tolerance of sulfasalazine in rheumatoid polyarthritis. Retrospective study of 95 patients].

  1992cites this paper
• The impact of endpoint measures in rheumatoid arthritis clinical trials.

  1992cites this paper
• [Treatment of rheumatoid spondylarthritis with salazosulfapyridine].

  1991cites this paper
• Disease-modifying agents and experimental treatments of rheumatoid arthritis.

  1991cites this paper
• Sulphasalazine in ankylosing spondylitis. A radiological, clinical and laboratory assessment

  1991cites this paper
• [Lupic serology caused by sulfasalazine].

  1991cites this paper
• Pharmacokinetics of Salazosulfapyridine (Sulfasalazine, SASP)(II)Tissue distribution and excretion of SASP in the rat after a single intravenous or oral administration.

  1991cites this paper
• Sulfasalazine therapy in psoriatic arthritis: clinical and immunologic response.

  1991cites this paper
• Drug metabolism by leukocytes and its role in drug-induced lupus and other idiosyncratic drug reactions.

  1990cites this paper
• Time for changes in the design, analysis, and reporting of rheumatoid arthritis clinical trials.

  1990cites this paper
• The use of sulphasalazine as a disease modifying antirheumatic drug.

  1990cites this paper
• Comparison of the single dose pharmacokinetics of sulphasalazine in rheumatoid arthritis and inflammatory bowel disease.

  1990cites this paper
• Termination of slow acting antirheumatic therapy in rheumatoid arthritis: a 14-year prospective evaluation of 1017 consecutive starts.

  1990cites this paper
• [Sulfasalazine for the treatment of rheumatoid polyarthritis. Results after 36 months].

  1990cites this paper
• The effect of folic acid supplementation on the toxicity of low-dose methotrexate in patients with rheumatoid arthritis.

  1990cites this paper
• Effect of sulphasalazine and sulphapyridine on neutrophil superoxide production: role of cytosolic free calcium.

  1990cites this paper
• A one-year, open, prospective study of sulfasalazine in the treatment of rheumatoid arthritis: adverse reactions and clinical response in relation to laboratory variables, drug and metabolite serum levels, and acetylator status.

  1990cites this paper
• The comparative efficacy and toxicity of second-line drugs in rheumatoid arthritis. Results of two metaanalyses.

  1990cites this paper
• Rheumatoid arthritis: current concepts and management, Part 2.

  1990cites this paper
• Fibrosing alveolitis due to sulphasalazine in a patient with rheumatoid arthritis.

  1990cites this paper
• [New prospects of immunotherapy in rheumatoid polyarthritis].

  1990cites this paper
• Clinical trials. A guide to understanding methodology and interpreting results.

  1990cites this paper